RTTNews | Mar 9, 2021 10:05AM EST

10:05 Tuesday, March 9, 2021 (RTTNews.com) - Auris Medical Holding Ltd. (EARS) shares are rising more than 33 percent on Tuesday morning trade as the clinical-stage company announced the initiation of a clinical investigation of AM-301 in allergic rhinitis with its affiliate Altamira Medica AG.

The company said the clinical investigation is an open-label randomized cross-over study that will enroll 36 patients with allergic rhinitis to grass pollen.

Currently, shares are at $4.55, up 33.03 percent from the previous close of $3.42 on a volume of 9,832,478. For the 52-week period, the shares have traded in a range of 0.65-$6.60 on average volume of 1,834,926.

Read the original article on RTTNews ( https://www.rttnews.com/3176054/stock-alert-auris-medical-gains-33-on-announcement-of-clinical-study-of-am-301.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved